Bell Investment Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.1K Buy
46
+8
+21% +$533 ﹤0.01% 1180
2026
Q1
$2.39K Buy
38
+8
+27% +$557 ﹤0.01% 1271
2025
Q4
$1.99K Sell
30
-48
-62% -$3.1K ﹤0.01% 1354
2025
Q3
$5.25K Sell
78
-27
-26% -$2.14K ﹤0.01% 914
2025
Q2
$9.17K Buy
105
+29
+38% +$2.27K ﹤0.01% 708
2025
Q1
$5.19K Buy
76
+19
+33% +$1.55K ﹤0.01% 895
2024
Q4
$4.43K Sell
57
-30
-34% -$2.22K ﹤0.01% 981
2024
Q3
$5.83K Sell
87
-41
-32% -$3.37K ﹤0.01% 855
2024
Q2
$14.5K Hold
128
﹤0.01% 476
2024
Q1
$17.8K Buy
128
+8
+7% +$1.01K ﹤0.01% 403
2023
Q4
$14.9K Buy
120
+3
+3% +$306 ﹤0.01% 430
2023
Q3
$10.9K Sell
117
-8
-6% -$902 ﹤0.01% 477
2023
Q2
$16.1K Sell
125
-29
-19% -$3.51K ﹤0.01% 356
2023
Q1
$17.9K Buy
154
+12
+8% +$1.34K ﹤0.01% 328
2022
Q4
$16.1K Buy
142
+35
+33% +$3.84K ﹤0.01% 353
2022
Q3
$9K Sell
107
-19
-15% -$1.61K ﹤0.01% 441
2022
Q2
$9K Buy
+126
New +$11.5K ﹤0.01% 455
2021
Q4
$19K Buy
140
+12
+9% +$1.72K 0.01% 321
2021
Q3
$17K Buy
+128
New +$16.1K 0.01% 320

Other funds holding DXCM

Bell Investment Advisors's DXCM Position: Q2 2026 in Review

Bell Investment Advisors increased its DexCom (DXCM) stake by 21% in Q2 2026, buying an estimated $533 and bringing the position to 46 shares worth $3.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1180.

Bell Investment Advisors first reported a position in DXCM in Q3 2021 and has held it in 19 quarters since. The position peaked at $19K in Q4 2021. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Bell Investment Advisors held 46 shares of DexCom worth $3.1K as of Q2 2026.
  • Bell Investment Advisors bought 8 DexCom shares in Q2 2026, an estimated $533.
  • DexCom made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #1180 holding.
  • Bell Investment Advisors first reported a position in DexCom in Q3 2021 and has held it in 19 quarters since.
  • Bell Investment Advisors's DexCom position peaked at $19K in Q4 2021.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.